Lpl Financial LLC Ultragenyx Pharmaceutical Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 8,370 shares of RARE stock, worth $395,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,370
Previous 6,071 37.87%
Holding current value
$395,398
Previous $249,000 86.35%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$40.21 - $59.36 $92,442 - $136,468
2,299 Added 37.87%
8,370 $464,000
Q2 2024

Aug 07, 2024
SELL
$37.42 - $51.61 $42,322 - $58,370
-1,131 Reduced 15.7%
6,071 $249,000
Q1 2024

May 10, 2024
SELL
$43.02 - $53.69 $516 - $644
-12 Reduced 0.17%
7,202 $336,000
Q4 2023

Feb 14, 2024
SELL
$31.73 - $49.19 $5,679 - $8,805
-179 Reduced 2.42%
7,214 $344,000
Q3 2023

Nov 13, 2023
SELL
$34.92 - $46.66 $1,431 - $1,913
-41 Reduced 0.55%
7,393 $263,000
Q2 2023

Jul 31, 2023
BUY
$37.35 - $52.15 $54,008 - $75,408
1,446 Added 24.15%
7,434 $342,000
Q1 2023

May 10, 2023
BUY
$36.99 - $48.71 $4,697 - $6,186
127 Added 2.17%
5,988 $240,000
Q4 2022

Feb 07, 2023
BUY
$33.72 - $46.33 $197,632 - $271,540
5,861 New
5,861 $271,000
Q2 2022

Aug 12, 2022
BUY
$45.8 - $85.4 $137 - $256
3 Added 0.06%
5,412 $323,000
Q1 2022

May 16, 2022
BUY
$62.2 - $84.4 $152,825 - $207,370
2,457 Added 83.23%
5,409 $393,000
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $39,582 - $47,180
537 Added 22.24%
2,952 $248,000
Q3 2021

Nov 15, 2021
BUY
$77.92 - $102.4 $1,714 - $2,252
22 Added 0.92%
2,415 $218,000
Q2 2021

Aug 13, 2021
SELL
$92.19 - $115.71 $26,642 - $33,440
-289 Reduced 10.78%
2,393 $228,000
Q1 2021

May 14, 2021
BUY
$106.9 - $167.73 $1,603 - $2,515
15 Added 0.56%
2,682 $305,000
Q4 2020

Feb 12, 2021
BUY
$84.4 - $177.39 $225,094 - $473,099
2,667 New
2,667 $369,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.31B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email